Literature DB >> 21600885

Extracellular histone induces plasma hyaluronan-binding protein (factor VII activating protease) activation in vivo.

Shingo Yamamichi1, Yukari Fujiwara, Tadashi Kikuchi, Miki Nishitani, Yasuhiko Matsushita, Keiji Hasumi.   

Abstract

Plasma hyaluronan-binding protein (PHBP), an activator of factor VII and prourokinase, is a serine protease circulating as a single-chain proenzyme (pro-PHBP). Pro-PHBP converts to the active two-chain form through autoproteolysis, and effectors that modulate autoactivation can regulate PHBP-mediated processes. Here, we show that histone promotes pro-PHBP autoactivation in vivo. Histone bound to pro-PHBP and promoted intermolecular pro-PHBP binding. Histone-mediated pro-PHBP activation in plasma leads to the formations of bradykinin and PHBP-α(2)-antiplasmin complex as well as histone degradation. Pro-PHBP activation was observed in the circulation of mice after injection of histone or lipopolysaccharide, which induced septic response accompanying extracellular histone release. Our results suggest pathophysiological relevance of histone-dependent pro-PHBP activation in hyperinflammatory process.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21600885     DOI: 10.1016/j.bbrc.2011.05.030

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  20 in total

1.  Histone H4 promotes prothrombin autoactivation.

Authors:  Sergio Barranco-Medina; Nicola Pozzi; Austin D Vogt; Enrico Di Cera
Journal:  J Biol Chem       Date:  2013-10-30       Impact factor: 5.157

2.  Dual effect of histone H4 on prothrombin activation.

Authors:  N Pozzi; E Di Cera
Journal:  J Thromb Haemost       Date:  2016-08-11       Impact factor: 5.824

3.  Role of extracellular histones in the cardiomyopathy of sepsis.

Authors:  Miriam Kalbitz; Jamison J Grailer; Fatemeh Fattahi; Lawrence Jajou; Todd J Herron; Katherine F Campbell; Firas S Zetoune; Markus Bosmann; J Vidya Sarma; Markus Huber-Lang; Florian Gebhard; Randall Loaiza; Hector H Valdivia; José Jalife; Mark W Russell; Peter A Ward
Journal:  FASEB J       Date:  2015-02-13       Impact factor: 5.191

4.  DNA and factor VII-activating protease protect against the cytotoxicity of histones.

Authors:  Gerben Marsman; Helen von Richthofen; Ingrid Bulder; Florea Lupu; Jan Hazelzet; Brenda M Luken; Sacha Zeerleder
Journal:  Blood Adv       Date:  2017-11-30

5.  Factor VII-activating protease promotes the proteolysis and inhibition of tissue factor pathway inhibitor.

Authors:  Sandip M Kanse; Paul J Declerck; Wolfram Ruf; George Broze; Michael Etscheid
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-11-23       Impact factor: 8.311

Review 6.  Histone cleavage as a mechanism for epigenetic regulation: current insights and perspectives.

Authors:  P Zhou; E Wu; H B Alam; Y Li
Journal:  Curr Mol Med       Date:  2014       Impact factor: 2.222

7.  Transforming Growth Factor-β (TGF-β) Inhibits the Expression of Factor VII-activating Protease (FSAP) in Hepatocytes.

Authors:  Silke Leiting; Sebastian Seidl; Adoracion Martinez-Palacian; Lars Muhl; Sandip M Kanse
Journal:  J Biol Chem       Date:  2016-07-26       Impact factor: 5.157

8.  The factor VII-activating protease (FSAP) enhances the activity of bone morphogenetic protein-2 (BMP-2).

Authors:  Elfie Kathrin Roedel; Elisabeth Schwarz; Sandip Madhav Kanse
Journal:  J Biol Chem       Date:  2013-01-22       Impact factor: 5.157

9.  Association of circulating factor seven activating protease (FSAP) and of oral Omega-3 fatty acids supplements with clinical outcome in patients with atrial fibrillation: the OMEGA-AF study.

Authors:  Mariana S Parahuleva; Sandip Kanse; Hans Hölschermann; Kirila Zheleva; Daniel Zandt; Michael Worsch; Behnoush Parviz; Norbert Güttler; Harald Tillmanns; Andreas Böning; Ali Erdogan
Journal:  J Thromb Thrombolysis       Date:  2014-04       Impact factor: 2.300

10.  Diabetes-independent increase of factor VII-activating protease activation in patients with Gram-negative sepsis (melioidosis).

Authors:  H K de Jong; G C K W Koh; I Bulder; F Stephan; W J Wiersinga; S S Zeerleder
Journal:  J Thromb Haemost       Date:  2014-12-06       Impact factor: 5.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.